Gilead Sciences (GILD) Operating Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
2,500.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-91.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
395.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-4,555.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-53.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,031.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-9,003.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-338.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,031.00 |
| Dec 31, 2025 |
-565.00 |
| Sep 30, 2025 |
254.00 |
| Jun 30, 2025 |
252.00 |
| Mar 31, 2025 |
3,056.00 |
| Dec 31, 2024 |
1,942.00 |
| Sep 30, 2024 |
-4,000.00 |
| Jun 30, 2024 |
189.00 |
| Mar 31, 2024 |
-10,964.00 |
| Dec 31, 2023 |
-1,306.00 |
| Sep 30, 2023 |
678.00 |
| Jun 30, 2023 |
8,323.00 |
| Mar 31, 2023 |
-1,645.00 |
| Dec 31, 2022 |
1,209.00 |
| Sep 30, 2022 |
6,657.00 |
| Jun 30, 2022 |
-1,033.00 |
| Mar 31, 2022 |
-3,937.00 |
| Dec 31, 2021 |
-676.00 |
| Sep 30, 2021 |
490.00 |
| Jun 30, 2021 |
-424.00 |
| Mar 31, 2021 |
268.00 |
| Dec 31, 2020 |
2,438.00 |
| Sep 30, 2020 |
-2,811.00 |
| Jun 30, 2020 |
-11,757.00 |
| Mar 31, 2020 |
-1,461.00 |
| Dec 31, 2019 |
-3,667.00 |
| Sep 30, 2019 |
-8,494.00 |
| Jun 30, 2019 |
-1,561.00 |
| Mar 31, 2019 |
-1,731.00 |
| Dec 31, 2018 |
-4,634.00 |
| Sep 30, 2018 |
-2,046.00 |
| Jun 30, 2018 |
-2,775.00 |
| Mar 31, 2018 |
-2,841.00 |
| Dec 31, 2017 |
-4,786.00 |
| Sep 30, 2017 |
94.00 |
| Jun 30, 2017 |
-794.00 |
| Mar 31, 2017 |
-296.00 |
| Dec 31, 2016 |
1,689.00 |
| Sep 30, 2016 |
1,741.00 |
| Jun 30, 2016 |
1,666.00 |
| Mar 31, 2016 |
1,918.00 |
| Dec 31, 2015 |
2,332.00 |
| Sep 30, 2015 |
2,431.00 |
| Jun 30, 2015 |
2,409.00 |
| Mar 31, 2015 |
3,567.00 |
| Dec 31, 2014 |
1,978.00 |
| Sep 30, 2014 |
1,029.00 |
| Jun 30, 2014 |
1,994.00 |
| Mar 31, 2014 |
1,404.00 |
| Dec 31, 2013 |
-313.00 |
| Sep 30, 2013 |
-928.00 |
| Jun 30, 2013 |
-981.00 |
| Mar 31, 2013 |
-1,518.00 |
| Dec 31, 2012 |
-966.00 |
| Sep 30, 2012 |
-663.00 |
| Jun 30, 2012 |
-217.00 |
| Mar 31, 2012 |
-1,776.00 |
